type ii

29
Type II Cytotoxic hypersensitivity Reaction time is minutes to hours mediated by antibodies of IgM or IgG class and complement Phagocytes and NK cells may also play a role (ADCC) . Diagnostic tests include detection of circulating antibody against tissues involved and the presence of antibody and complement in the lesion (biopsy) by immunofluorescence Directed against cell surface or tissue antigen

Upload: liseli

Post on 08-Feb-2016

41 views

Category:

Documents


0 download

DESCRIPTION

Type II. Cytotoxic hypersensitivity Reaction time is minutes to hours mediated by antibodies of IgM or IgG class and complement Phagocytes and NK cells may also play a role (ADCC). Diagnostic tests include detection of - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Type II

Type II•Cytotoxic hypersensitivity

•Reaction time is minutes to hours•mediated by antibodies of IgM or IgG

class and complement•Phagocytes and NK cells may also play a role

(ADCC).•Diagnostic tests include detection of

circulating antibody against tissues involved and the presence of antibody and complement in the lesion (biopsy) by immunofluorescence

•Directed against cell surface or tissue antigen

Page 2: Type II

Clinical Examples• Transfusion reactions• Autoimmune Hemolytic anemia• Hemolytic disease of newborn• Drug induced hemolytic anemia• Autoimmune thrombocytopenia• Pemphigus vulgaris(desmoglein )• Goodpastures syndrome• Myasthenia gravis• Graves disease• Insulin resistant diabetes• Pernicious anemia• others

Page 3: Type II

Drugs that can cause this type of hemolytic anemia include:

• Cephalosporins (a class of antibiotics) • Levodopa • Methyldopa • Penicillin and its derivatives • Quinidine • Some nonsteroidal anti-inflammatory

drugs (NSAIDs)

Page 4: Type II

Type III

• The reaction may be general (e.g., serum sickness) or may involve individual organs including skin ( Arthus reaction), kidneys, lungs, blood vessels , joints or other organs.

Page 5: Type II

Type III

• It is mediated by soluble immune complexes

• The reaction may take few hours after exposure to the antigen

• The lesion contains primarily neutrophils

Page 6: Type II

Immune complex mediated diseases

• Immune complexes cause disease only:1-in excessive amounts2- not efficiently cleared3- become deposited in tissuesa) intermediate complexes tend to be deposited

in vesselsb) Cationic antigens bind to negatively charged

components of the basement membranes of blood vessels and glomeruli,joints

Page 7: Type II

Tissue injury mechanisms

• Antibodies may opsonize cells or activate the complement system

Production of complement proteins that opsonize cells.

These cells are phagocytosed and destroyed by phagocytes that express FcR and CR

Main mechanism in autoimmune hemolytic anemia and thrombocytopenia and hemolysis in transfusion reactions.

Page 8: Type II

Cell Mediated Immunity

• The effector cells involved in these processes are cytotoxic T-lymphocytes (CTLs), NK-cells and Th cells

Phagocytosis and killing of intracellular pathogens Direct cell killing by cytotoxic T cells Direct cell killing by NK and K cells • These responses are especially important for

destroying intracellular bacteria, eliminating viral infections and destroying tumor cells

Page 9: Type II

• Response to microbes residing within the phagosomes is mediated by effector CD4 Th1 cells

• Microbes that infect and replicate in nonphagocytic cells,is mediated by CD8

• T cell dependent macrophage activation and inflammation may damage normal tissues

Page 10: Type II

• Th1(IFN- )• Th2(IL-4,IL-5)• Th17(TGF-,IL-1,IL-6)• The most differentiation –inducing stimuli

are IFN- ,IL-12 and IL-4

Page 11: Type II

Killing by cytotoxic T cells

• release some substances known as perforin ,Granzyme A,B ,C and serglycin and granulysin

• the CTL may release lymphokines and/or cytokines

Page 12: Type II

• Recognition• Activation• Lethal hit• Release(cathepsin B)

Page 13: Type II

Type IV hypersensitivity

Page 14: Type II

Type IV hypersensitivity• DTH (Delayed type hyper sensitivity)• Is a T cell mediated inflammatory response ,in which

stimulation of T cells leads to macrophage activation and localised inflammation and edema within tissues.

• This effector T cell response is essential for the control of intracellular and other pathogens.

• If the response is excessive it can damage host tissues• Subsequent exposure of the sensitised individual to the

exogenous Ag results in the recruitment of specific T cells to the site and development of a local inflammatory response over 24-72 hrs.

Page 15: Type II
Page 16: Type II

Interferon production

Page 17: Type II

TDTH formation

Page 18: Type II

variants of type IV HS

There are 3 variants of type IV HS reaction• Contact HS• Tuberculin type HS• Granulomatous HS

Page 19: Type II

Contact hypersensitivity

• Occur within 72 hrs of Ag challenge• Characterized by an eczematous reaction

in the skin at the point of contact with an allergen

• Organic chemicals and inorganic metals such as nickel , chromate and rubber accelerator in latex gloves

Page 20: Type II

Contact hypersensitivity

Has 2 stage• Sensitization • elicitation

Page 21: Type II
Page 22: Type II
Page 23: Type II
Page 24: Type II

TUBERCULIN TYPE

• Is induced by soluble antigens from organisms such as M.Tuberculosis and Leprae and leishmania tropica

• Following ID tuberculin challenge memory T cells are recruited and activated to secrete IFN- ,which activates Macrophages to produce TNF and IL-1

• The initial influx at 4 hrs is neutrophils but replaced at 12 hrs by monocytes and T cells.

Page 25: Type II

PPD skin test

Page 26: Type II

Granulomatous HS

• Clinically the most important form of type IV HS.

• If the Ag persist(intracellular micro.,other particles such as ziconium and beryllium ,talc ,silica) ,chronic activation of T cells and macrophages lead to granuloma formation and tissue damage.

Page 27: Type II
Page 28: Type II

Granulomatous HS

The Granuloma contains :• Epithelioid cells (secret TNF)• Langhans giant cells(low ER and

degeneration of lysosomes and mitochondria)

• MacrophagesIFN- and TNF are essential for granuloma

formation

Page 29: Type II

Granulomatous HS

• Crohn disease(chronic inflammatory disease of ileum and colon)

• Leishmaniasis• Sarcoidosis• Leprosy• tuberculosis